News of the first takers of the desperately awaited Pfizer-BioNTech coronavirus vaccine spurred some hope and excitement amid new lockdowns and spiraling infections in much of the US and the UK. But in Russia, one of the few countries already offering vaccines to a wider segment of the general public, the turnout in the first two weeks of “large-scale” vaccination has been less than enthusiastic.
Here’s how brain-eating amoebas may infect people 
A video of a humpback whale and her dead calf reveals the animals’ bond 
A new map points out U.S. rivers most worth protecting 
Exhaling may speed up reaction times 
A medieval remedy could offer ideas for beating antibiotic resistance 
In the wake of the flood, could Nepal avert the next disaster? 
‘Women are not victims’: Türk calls for women to be at the heart of peace and security 
World News in Brief: Marshall Islands nuclear legacy, FlyDubai attack condemned, Ukraine update, breast cancer treatment expanded in West Bank 
No more execution attempts on Christa Pike: UN rights chief 
UN Member States weigh latest Security Council veto, this time on Iran